Status:
COMPLETED
Fibrinolysis Compared to Thoracoscopy for Pleural Infection
Lead Sponsor:
Tulane University
Conditions:
Pleural Infection
Empyema
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: Medical thoracoscopy as compared to instillation of intrapleural t...
Detailed Description
Background: Pleural infection (empyema or complex parapneumonic effusion (CPPE)) represents one of the most common clinical diagnoses encountered in clinical practice in the United States (US) It is a...
Eligibility Criteria
Inclusion
- Subjects \>18 years old with:
- Evidence of empyema or complex parapneumonic effusion
Exclusion
- Age \<18 years Pregnancy Inability to give informed written consent Previous thoracic surgery or thrombolytic therapy for pleural infection Medical thoracoscopy cannot be performed within 48 hours Hemodynamic instability or severe hypoxemia Non corrected coagulopathy Homogeneously echogenic effusion on pleural ultrasonography
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03468933
Start Date
November 1 2017
End Date
December 30 2019
Last Update
February 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tulane Medical Center Tulane University Section of Pulmonary DiseasesTulane University Section of Pulmonary Diseases
New Orleans, Louisiana, United States, 70112